Home
>
National Drug Code (NDC)
>
Loxapine
Loxapine - 0591-0371-01 - (Loxapine)
Drug Information of Loxapine
| Product NDC: | 0591-0371 |
| Proprietary Name: | Loxapine |
| Non Proprietary Name: | Loxapine |
| Active Ingredient(s): | 25 mg/1 & nbsp; Loxapine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Loxapine
| Product NDC: | 0591-0371 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA072206 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19880615 |
Package Information of Loxapine
| Package NDC: | 0591-0371-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-0371-01) |
NDC Information of Loxapine
| NDC Code | 0591-0371-01 |
| Proprietary Name | Loxapine |
| Package Description | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-0371-01) |
| Product NDC | 0591-0371 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Loxapine |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19880615 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | LOXAPINE SUCCINATE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
